Profound Medical
PROF
43 hedge funds and large institutions have $80.4M invested in Profound Medical in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 7 closing their positions.
1,175% more call options, than puts
Call options by funds: $306K | Put options by funds: $24K
3% more capital invested
Capital invested by funds: $77.8M → $80.4M (+$2.63M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 45 → 43 (-2)
4.51% less ownership
Funds ownership: 43.51% → 39% (-4.5%)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
+$2.04M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$1.25M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.21M |
| 4 |
GA
Gagnon Advisors
New York
|
+$567K |
| 5 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$447K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$1.37M |
| 2 |
KC
Kepos Capital
New York
|
-$849K |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$434K |
| 4 |
ZDA
Zweig-DiMenna Associates
New York
|
-$220K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$131K |
PROF Hedge Fund Activity: Q1 2024 in Review
43 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2024, worth a combined $80.4M — up 3.4% from $77.8M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PROF and 5 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 11 added.
The largest buyer was Timelo Investment Management, adding an estimated $2.04M. The largest seller was Worth Venture Partners, exiting entirely with an estimated $1.37M sold.
- 43 institutional investors held Profound Medical (PROF) as of Q1 2024, down from 45 in Q4 2023.
- Funds reported $80.4M of Profound Medical stock for Q1 2024, up 3.4% quarter-over-quarter.
- 5 funds opened new Profound Medical positions in Q1 2024 and 7 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q1 2024 was Timelo Investment Management, an estimated $2.04M added.
- The largest Profound Medical seller in Q1 2024 was Worth Venture Partners, an estimated $1.37M sold.
Based on aggregated 13F filings for Q1 2024.